STOCK TITAN

22nd Century Group Inc - XXII STOCK NEWS

Welcome to our dedicated news page for 22nd Century Group (Ticker: XXII), a resource for investors and traders seeking the latest updates and insights on 22nd Century Group.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect 22nd Century Group's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of 22nd Century Group's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.91%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.31%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.91%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.4%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.04%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.12%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.66%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.48%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.75%
Tags
none
22nd Century Group Inc

Nasdaq:XXII

XXII Rankings

XXII Stock Data

9.41M
3.28M
0.65%
6.58%
5.51%
Tobacco Manufacturing
Manufacturing
Link
United States
Mocksville

About XXII

with the mission of reducing the harm caused by smoking, 22nd century is a plant biotechnology company whose proprietary technology allows for the levels of nicotine in the tobacco plant to be decreased or increased through genetic engineering and plant breeding. goodrich tobacco company and hercules pharmaceuticals are wholly-owned subsidiaries focusing on (i) premium cigarettes and potentially reduced risk tobacco products (with up to 97% less nicotine than conventional cigarettes), and (ii) the x-22 prescription smoking cessation aid in development. 22nd century's technology also allows the levels of cannabinoids to be decreased or increased in the cannabis plant.